The Need for Mathematical Modelling of Spatial Drug Distribution Within the Brain

Overview

Journal Fluids Barriers CNS

Publisher Biomed Central

Date 2019 May 17

PMID 31092261

Citations 27

Authors

Esmee Vendel

Vivi Rottschafer

Elizabeth C M de Lange

Affiliations

Soon will be listed here.

Abstract

The blood brain barrier (BBB) is the main barrier that separates the blood from the brain. Because of the BBB, the drug concentration-time profile in the brain may be substantially different from that in the blood. Within the brain, the drug is subject to distributional and elimination processes: diffusion, bulk flow of the brain extracellular fluid (ECF), extra-intracellular exchange, bulk flow of the cerebrospinal fluid (CSF), binding and metabolism. Drug effects are driven by the concentration of a drug at the site of its target and by drug-target interactions. Therefore, a quantitative understanding is needed of the distribution of a drug within the brain in order to predict its effect. Mathematical models can help in the understanding of drug distribution within the brain. The aim of this review is to provide a comprehensive overview of system-specific and drug-specific properties that affect the local distribution of drugs in the brain and of currently existing mathematical models that describe local drug distribution within the brain. Furthermore, we provide an overview on which processes have been addressed in these models and which have not. Altogether, we conclude that there is a need for a more comprehensive and integrated model that fills the current gaps in predicting the local drug distribution within the brain.

Citing Articles

Mechanistic Modeling of Spatial Heterogeneity of Drug Penetration and Exposure in the Human Central Nervous System and Brain Tumors.

Li J, Wickramasinghe C, Jiang J, Wu A, Jiang Y, Tovmasyan A Clin Pharmacol Ther. 2024; 117(3):690-703.

PMID: 39575553 PMC: 11835533. DOI: 10.1002/cpt.3505.

Perspective Strategies for Interventions in Parkinsonism: Remedying the Neglected Role of TPPP.

Olah J, Norris V, Lehotzky A, Ovadi J Cells. 2024; 13(4.

PMID: 38391951 PMC: 10886726. DOI: 10.3390/cells13040338.

Pharmacokinetic Model-Based Control across the Blood-Brain Barrier for Circadian Entrainment.

Murdoch S, Aiello E, Doyle 3rd F Int J Mol Sci. 2023; 24(19).

PMID: 37834278 PMC: 10573769. DOI: 10.3390/ijms241914830.

Surgical Management of Brain Tumors with Focused Ultrasound.

Mehkri Y, Pierre K, Woodford S, Davidson C, Urhie O, Sriram S Curr Oncol. 2023; 30(5):4990-5002.

PMID: 37232835 PMC: 10217559. DOI: 10.3390/curroncol30050377.

Application of a multicomponent model of convectional reaction-diffusion to description of glucose gradients in a neurovascular unit.

Nartsissov Y Front Physiol. 2022; 13:843473.

PMID: 36072843 PMC: 9444140. DOI: 10.3389/fphys.2022.843473.

References

Hrabe J, Hrabetova S, Segeth K . A model of effective diffusion and tortuosity in the extracellular space of the brain. Biophys J. 2004; 87(3):1606-17. PMC: 1304566. DOI: 10.1529/biophysj.103.039495. View

Di Giovanna A, Tibo A, Silvestri L, Mullenbroich M, Costantini I, Allegra Mascaro A . Whole-Brain Vasculature Reconstruction at the Single Capillary Level. Sci Rep. 2018; 8(1):12573. PMC: 6105658. DOI: 10.1038/s41598-018-30533-3. View

Linninger A, Somayaji M, Erickson T, Guo X, Penn R . Computational methods for predicting drug transport in anisotropic and heterogeneous brain tissue. J Biomech. 2008; 41(10):2176-87. DOI: 10.1016/j.jbiomech.2008.04.025. View

Tao A, Tao L, Nicholson C . Cell cavities increase tortuosity in brain extracellular space. J Theor Biol. 2005; 234(4):525-36. DOI: 10.1016/j.jtbi.2004.12.009. View

Hoffmann J, Fichtner I, Lemm M, Lienau P, Hess-Stumpp H, Rotgeri A . Sagopilone crosses the blood-brain barrier in vivo to inhibit brain tumor growth and metastases. Neuro Oncol. 2008; 11(2):158-66. PMC: 2718987. DOI: 10.1215/15228517-2008-072. View

Tzafriri A, Groothuis A, Price G, Edelman E . Stent elution rate determines drug deposition and receptor-mediated effects. J Control Release. 2012; 161(3):918-26. PMC: 3616625. DOI: 10.1016/j.jconrel.2012.05.039. View

Smith A, Doyeux V, Berg M, Peyrounette M, Haft-Javaherian M, Larue A . Brain Capillary Networks Across Species: A few Simple Organizational Requirements Are Sufficient to Reproduce Both Structure and Function. Front Physiol. 2019; 10:233. PMC: 6444172. DOI: 10.3389/fphys.2019.00233. View

Hawkins B, Davis T . The blood-brain barrier/neurovascular unit in health and disease. Pharmacol Rev. 2005; 57(2):173-85. DOI: 10.1124/pr.57.2.4. View

Copeland R, Pompliano D, Meek T . Drug-target residence time and its implications for lead optimization. Nat Rev Drug Discov. 2006; 5(9):730-9. DOI: 10.1038/nrd2082. View

10.

Yamamoto Y, Valitalo P, van den Berg D, Hartman R, van den Brink W, Wong Y . A Generic Multi-Compartmental CNS Distribution Model Structure for 9 Drugs Allows Prediction of Human Brain Target Site Concentrations. Pharm Res. 2016; 34(2):333-351. PMC: 5236087. DOI: 10.1007/s11095-016-2065-3. View

11.

Morrison P, Laske D, Bobo H, Oldfield E, Dedrick R . High-flow microinfusion: tissue penetration and pharmacodynamics. Am J Physiol. 1994; 266(1 Pt 2):R292-305. DOI: 10.1152/ajpregu.1994.266.1.R292. View

12.

Nicholson C, Phillips J . Diffusion from an iontophoretic point source in the brain: role of tortuosity and volume fraction. Brain Res. 1979; 169(3):580-4. DOI: 10.1016/0006-8993(79)90408-6. View

13.

Westerhout J, Danhof M, de Lange E . Preclinical prediction of human brain target site concentrations: considerations in extrapolating to the clinical setting. J Pharm Sci. 2011; 100(9):3577-93. DOI: 10.1002/jps.22604. View

14.

Pardridge W . Receptor-mediated peptide transport through the blood-brain barrier. Endocr Rev. 1986; 7(3):314-30. DOI: 10.1210/edrv-7-3-314. View

15.

Marroni M, Marchi N, Cucullo L, Abbott N, Signorelli K, Janigro D . Vascular and parenchymal mechanisms in multiple drug resistance: a lesson from human epilepsy. Curr Drug Targets. 2003; 4(4):297-304. DOI: 10.2174/1389450033491109. View

16.

Abbott N, Patabendige A, Dolman D, Yusof S, Begley D . Structure and function of the blood-brain barrier. Neurobiol Dis. 2009; 37(1):13-25. DOI: 10.1016/j.nbd.2009.07.030. View

17.

Urquhart B, Kim R . Blood-brain barrier transporters and response to CNS-active drugs. Eur J Clin Pharmacol. 2009; 65(11):1063-70. DOI: 10.1007/s00228-009-0714-8. View

18.

Ehlers W, Wagner A . Multi-component modelling of human brain tissue: a contribution to the constitutive and computational description of deformation, flow and diffusion processes with application to the invasive drug-delivery problem. Comput Methods Biomech Biomed Engin. 2013; 18(8):861-79. DOI: 10.1080/10255842.2013.853754. View

19.

Villringer A, Them A, Lindauer U, Einhaupl K, Dirnagl U . Capillary perfusion of the rat brain cortex. An in vivo confocal microscopy study. Circ Res. 1994; 75(1):55-62. DOI: 10.1161/01.res.75.1.55. View

20.

Linninger A, Gould I, Marrinan T, Hsu C, Chojecki M, Alaraj A . Cerebral microcirculation and oxygen tension in the human secondary cortex. Ann Biomed Eng. 2013; 41(11):2264-84. PMC: 3878164. DOI: 10.1007/s10439-013-0828-0. View